Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology and Director of the Byers Eye Institute at Stanford University. His clinical effort is focused on patients in need of medical or surgical intervention for glaucoma and other retinal and optic nerve diseases, as well as cataract. His research is directed at neuroprotection and regeneration of retinal ganglion cells and the optic nerve, a major unmet need in glaucoma and other optic neuropathies, and his laboratory is developing novel molecular, stem cell and nanotherapeutics approaches for eye repair.
Dr. Goldberg received his BS magna cum laude from Yale University, and his MD and PhD from Stanford University where he made significant discoveries about the failure of optic nerve regeneration. He did his clinical training in ophthalmology followed by glaucoma at the Bascom Palmer Eye Institute, and was awarded a fellowship from the Heed Foundation. Dr. Goldberg was named the 2010 Scientist of the Year by the Hope For Vision foundation, and received the Cogan award from the Association for Research in Vision and Ophthalmology in 2012. He was elected in 2010 to the American Society of Clinical Investigation, an honorary society of physician scientists. He directs an NIH-funded research laboratory and is one of the scientists funded by the National Eye Institute’s Audacious Goals Initiative. In addition, Dr. Goldberg has developed significant expertise with implementing FDA clinical trials for optic nerve neuroprotection and regeneration. His goal is to translate scientific discoveries to patient therapies.